Cargando…
Evaluation of efficacy of metoprolol in patients having heart failure with preserved ejection fraction: A randomized, double-blind, placebo-controlled pilot trial
BACKGROUND: There is a lack of evidence-based therapies for the treatment of heart failure (HF) with preserved ejection fraction (HFpEF). Beta blockers may provide some benefit in HFpEF due to their proven role in HF with reduced ejection fraction. AIM: The main objective of the present study was to...
Autores principales: | Mittal, Niti, Shafiq, Nusrat, Reddy, Sreenivas, Malhotra, Samir, Kumari, Savita, Varma, Subhash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543763/ https://www.ncbi.nlm.nih.gov/pubmed/28828307 http://dx.doi.org/10.4103/2229-3485.210449 |
Ejemplares similares
-
A prospective observational study on different poisoning cases and their outcomes in a tertiary care hospital
por: Mittal, Niti, et al.
Publicado: (2013) -
Drug Utilisation Study in a Tertiary Care Center: Recommendations for Improving Hospital Drug Dispensing Policies
por: Mittal, Niti, et al.
Publicado: (2014) -
Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016) -
Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Samuel, Tal Y., et al.
Publicado: (2021) -
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)